Paper334241
Ribosome-tetracycline interactions.
Tritton TR. Biochemistry, 1977. Cited by 65 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Ribosome-tetracycline interactions. Papers, record 334241. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/334241
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ribosomes | Major topic |
| Tetracycline | Major topic |
| Binding Sites | |
| Dose-Response Relationship, Drug | |
| Escherichia coli | |
| Kinetics | |
| Magnesium | |
| Peptide Biosynthesis | |
| Phenylalanine | |
| Protein Biosynthesis | |
| Spectrometry, Fluorescence | |
| Temperature |
Source PubMed
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,613,253 | Probing Antibiotic Inhibition in Small Bacterial Populations With Combinatorial Droplet Microfluidics. | Small Sci | 2026 | https://conductscience.org/library/papers/41613253 | PubMed |
| 33,664,488 | Metabolic fitness landscapes predict the evolution of antibiotic resistance. | Nat Ecol Evol | 2021 | https://conductscience.org/library/papers/33664488 | PubMed |
| 33,136,210 | Tetracycline and viruses: a possible treatment for COVID-19? | Arch Virol | 2021 | https://conductscience.org/library/papers/33136210 | PubMed |
| 32,782,250 | Mechanisms of drug interactions between translation-inhibiting antibiotics. | Nat Commun | 2020 | https://conductscience.org/library/papers/32782250 | PubMed |
| 28,174,311 | A Numbers Game: Ribosome Densities, Bacterial Growth, and Antibiotic-Mediated Stasis and Death. | mBio | 2017 | https://conductscience.org/library/papers/28174311 | PubMed |
| 28,060,813 | Using Chemical Reaction Kinetics to Predict Optimal Antibiotic Treatment Strategies. | PLoS Comput Biol | 2017 | https://conductscience.org/library/papers/28060813 | PubMed |
| 27,212,408 | Complex Interplay of Physiology and Selection in the Emergence of Antibiotic Resistance. | Curr Biol | 2016 | https://conductscience.org/library/papers/27212408 | PubMed |
| 26,579,393 | Antibiotic drugs targeting bacterial RNAs. | Acta Pharm Sin B | 2014 | https://conductscience.org/library/papers/26579393 | PubMed |
| 26,146,675 | Growth-dependent bacterial susceptibility to ribosome-targeting antibiotics. | Mol Syst Biol | 2015 | https://conductscience.org/library/papers/26146675 | PubMed |
| 25,972,005 | Classic reaction kinetics can explain complex patterns of antibiotic action. | Sci Transl Med | 2015 | https://conductscience.org/library/papers/25972005 | PubMed |
| 20,951,211 | Tetracycline compounds with non-antimicrobial organ protective properties: possible mechanisms of action. | Pharmacol Res | 2011 | https://conductscience.org/library/papers/20951211 | PubMed |
| 20,592,239 | Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature. | Am J Physiol Cell Physiol | 2010 | https://conductscience.org/library/papers/20592239 | PubMed |
| 16,723,578 | Functional, biophysical, and structural bases for antibacterial activity of tigecycline. | Antimicrob Agents Chemother | 2006 | https://conductscience.org/library/papers/16723578 | PubMed |
| 14,638,464 | Ribosomal protection proteins and their mechanism of tetracycline resistance. | Antimicrob Agents Chemother | 2003 | https://conductscience.org/library/papers/14638464 | PubMed |
| 12,574,130 | Mechanism of Tet(O)-mediated tetracycline resistance. | EMBO J | 2003 | https://conductscience.org/library/papers/12574130 | PubMed |
| 9,696,754 | Binding interaction between Tet(M) and the ribosome: requirements for binding. | J Bacteriol | 1998 | https://conductscience.org/library/papers/9696754 | PubMed |
| 9,092,632 | Interaction of tetracycline with RNA: photoincorporation into ribosomal RNA of Escherichia coli. | Nucleic Acids Res | 1997 | https://conductscience.org/library/papers/9092632 | PubMed |
| 6,901,544 | Ribosomal function and its inhibition by antibiotics in prokaryotes. | Naturwissenschaften | 1980 | https://conductscience.org/library/papers/6901544 | PubMed |
| 6,758,689 | Transport of the lipophilic analog minocycline differs from that of tetracycline in susceptible and resistant Escherichia coli strains. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6758689 | PubMed |
| 6,423,382 | The binding of 6-demethylchlortetracycline to 70S, 50S and 30S ribosomal particles: a quantitative study by fluorescence anisotropy. | EMBO J | 1984 | https://conductscience.org/library/papers/6423382 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/334241
GET https://conductscience.org/api/papers/v1/334241/cited_by?page=2